JREU:F:F-JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 51.08

Change

+0.15 (+0.29)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.18 (-0.64%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.49 (+0.95%)

USD 120.02B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 101.84B
SXR8:F iShares Core S&P 500 UCITS ETF..

-6.54 (-1.19%)

USD 90.91B
FRCJ:F UBS MSCI Japan Socially Respon..

-0.18 (-0.79%)

USD 75.38B
EUNL:F iShares Core MSCI World UCITS ..

-0.55 (-0.57%)

USD 72.04B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.09 (-0.59%)

USD 60.46B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 59.23B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.81 (-0.83%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

-0.80 (-0.82%)

USD 51.63B

ETFs Containing JREU:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.22% 90% A- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.22% 87% B+ 72% C
Trailing 12 Months  
Capital Gain 28.91% 85% B 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.91% 83% B 71% C-
Trailing 5 Years  
Capital Gain 115.66% 98% N/A 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 115.66% 98% N/A 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 16.50% 94% A 82% B
Dividend Return 16.50% 93% A 76% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.13% 39% F 73% C
Risk Adjusted Return 109.08% 99% N/A 98% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.